126 tracked 13F filers disclose a position in RZLT as of the latest SEC 13F filings, a combined $285.2M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | FEDERATED HERMES, INC. | $39.6M | 13.0M | ▼−21% Reduced · −3.5M sh | Q1 2026 | |
| 2 | RA CAPITAL MANAGEMENT, L.P. | $28.0M | 9.2M | —Held | Q1 2026 | |
| 3 | BlackRock, Inc. | $19.3M | 6.3M | ▼−6.7% Reduced · −455K sh | Q1 2026 | |
| 4 | Opaleye Management Inc. | $19.2M | 6.3M | ▲+0.2% Added · +13K sh | Q1 2026 | |
| 5 | BALYASNY ASSET MANAGEMENT L.P. | $15.4M | 5.0M | ▲+12% Added · +542K sh | Q1 2026 | |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $10.7M | 3.5M | →First observed position No prior filed position | Q1 2026 | |
| 7 | JENNISON ASSOCIATES LLC | $10.5M | 3.4M | ▲New +3.4M sh | Q1 2026 | |
| 8 | Siren, L.L.C. | $17.3M | 3.3M | —Held | Q2 2026 | |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | $9.1M | 3.0M | →First observed position No prior filed position | Q1 2026 | |
| 10 | BANK OF AMERICA CORP /DE/ | $9.1M | 3.0M | ▼−31% Reduced · −1.4M sh | Q1 2026 | |
| 11 | MORGAN STANLEY | $8.4M | 2.7M | ▲+81% Added · +1.2M sh | Q1 2026 | |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $11.3M | 2.2M | ▲+10% Added · +206K sh | Q2 2026 | |
| 13 | UBS Group AG | $5.9M | 1.9M | ▼−31% Reduced · −878K sh | Q1 2026 | |
| 14 | STATE STREET CORP | $9.6M | 1.9M | ▲+4.4% Added · +78K sh | Q2 2026 | |
| 15 | D. E. Shaw & Co., Inc. | $5.4M | 1.8M | ▲+608% Added · +1.5M sh | Q1 2026 | |
| 16 | Affinity Asset Advisors, LLC | $4.7M | 1.5M | ▼−34% Reduced · −804K sh | Q1 2026 | |
| 17 | MILLENNIUM MANAGEMENT LLC | $4.6M | 1.5M | ▼−11% Reduced · −194K sh | Q1 2026 | |
| 18 | KENNEDY CAPITAL MANAGEMENT LLC | $3.8M | 1.2M | ▲+77% Added · +538K sh | Q1 2026 | |
| 19 | GREAT POINT PARTNERS LLC | $2.9M | 952K | —Held | Q1 2026 | |
| 20 | TWO SIGMA INVESTMENTS, LP | $2.5M | 831K | ▲New +831K sh | Q1 2026 | |
| 21 | 22NW, LP | $2.5M | 821K | —Held | Q1 2026 | |
| 22 | AQR CAPITAL MANAGEMENT LLC | $2.4M | 797K | ▲+194% Added · +526K sh | Q1 2026 | |
| 23 | Velan Capital Investment Management LP | $3.9M | 750K | —Held | Q2 2026 | |
| 24 | Sixth Street Partners Management Company, L.P. | $3.8M | 724K | ▲New +724K sh | Q2 2026 | |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.9M | 638K | ▼−4.0% Reduced · −27K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 14 funds opened a new position in RZLT and 16 added to an existing one, while 10 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 53 funds | $34.0B |
| NVIDIA CORPNVDA | 51 funds | $162.8B |
| MICRON TECHNOLOGY INCMU | 51 funds | $13.6B |
| AMAZON.COM INCAMZN | 50 funds | $79.9B |
| MICROSOFT CORPMSFT | 49 funds | $106.4B |
| ALPHABET INC-CL AGOOGL | 49 funds | $59.4B |
| UNITEDHEALTH GROUP INCUNH | 49 funds | $13.1B |
| VERTEX PHARMACEUTICALS INCVRTX | 49 funds | $5.9B |
| INSMED INCINSM | 49 funds | $3.3B |
| CENTENE CORPCNC | 49 funds | $2.5B |
| WAVE LIFE SCIENCES LTDWVE | 49 funds | $418.8M |
| ANNEXON INCANNX | 49 funds | $158.4M |
Ranked by how many of RZLT's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Mar 30, 2026 | Evans Daron | CFO | Buy (P) | 10K | $29K |
| Dec 16, 2025 | ROBERTS BRIAN KENNETH | Chief Medical Officer | Buy (P) | 28K | $48K |
| Dec 16, 2025 | Hogenhuis Wladimir | Director | Buy (P) | 6K | $10K |
| Dec 15, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | Buy (P) | 100 | $160 |
| Dec 15, 2025 | Karnawat Sunil Ratilal | Chief Commercial Officer | Buy (P) | 12K | $19K |
| Dec 15, 2025 | Elam Nevan C | CEO, Director | Buy (P) | 32K | $51K |
| Dec 15, 2025 | Evans Daron | CFO | Buy (P) | 40K | $71K |
| Dec 15, 2025 | Evans Daron | CFO | Buy (P) | 3K | $4K |
| Dec 15, 2025 | Evans Daron | CFO | Buy (P) | 3K | $4K |
| Jun 25, 2025 | ROBERTS BRIAN KENNETH | Chief Medical Officer | Buy (P) | 3K | $11K |
| Jun 24, 2025 | Evans Daron | CFO | Buy (P) | 5K | $20K |
| Jun 13, 2025 | KREHER NERISSA | Director | Buy (P) | 3K | $10K |
Connected entities for RZLT
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/RZLT/capital-change-brief"
Use Arkolith's capital_change_brief for RZLT. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for RZLT. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.